Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105166821> ?p ?o ?g. }
- W2105166821 endingPage "311" @default.
- W2105166821 startingPage "311" @default.
- W2105166821 abstract "Purpose: Although many tumor markers have been evaluated in relation to bladder cancer, none of these biomarkers reported to date has shown sufficient sensitivity and specificity for the detection of the whole spectrum of bladder cancer diseases in routine clinical practice. The limited value of the established prognostic markers requires analysis of new molecular parameters of interest for predicting the prognosis of bladder cancer patients. Materials and Methods: We conducted a review of the literature with a focus on recent advances in genetic polymorphism and hypermethylation events in relation to bladder transitional cell carcinoma. Results: Recently, there has been major progress in both genetic polymorphism in relation to bladder cancer and molecular genetic and epigenetic changes leading to the development of transitional cell carcinoma. However, studies on numerous single-nucleotide polymorphisms in relation to bladder cancer have provided only a few genetic polymorphisms with only marginal information on patients’ prognosis. For this reason, interest is increasing in epigenetic changes in bladder cancer. The epigenetic silencing of tumor suppressor genes is interesting from a clinical standpoint because of the possibility to reverse the epigenetic changes and thus restore gene function to a cell. Treatment with DNA methylation inhibitors can restore the activities of dormant genes and decrease the growth rate of cancer cells in a heritable fashion. Conclusions: Epigenetic modification may be possible to partially reverse the cancer phenotype, and this will eventually lead to targeted therapy tailored toward specific molecular therapy in the near future. (Korean J" @default.
- W2105166821 created "2016-06-24" @default.
- W2105166821 creator A5028262111 @default.
- W2105166821 creator A5051087755 @default.
- W2105166821 date "2009-01-01" @default.
- W2105166821 modified "2023-10-16" @default.
- W2105166821 title "Can We Use Single Nucleotide Polymorphism and Runt Domain Transcription Factor 3 Methylation as Tumor Markers for Bladder Cancer?" @default.
- W2105166821 cites W1044883788 @default.
- W2105166821 cites W1489006980 @default.
- W2105166821 cites W1489080401 @default.
- W2105166821 cites W1503352598 @default.
- W2105166821 cites W1507439883 @default.
- W2105166821 cites W1531748014 @default.
- W2105166821 cites W1552528612 @default.
- W2105166821 cites W1556996865 @default.
- W2105166821 cites W1559870962 @default.
- W2105166821 cites W1565561072 @default.
- W2105166821 cites W1581272510 @default.
- W2105166821 cites W1597992152 @default.
- W2105166821 cites W1603098046 @default.
- W2105166821 cites W1611268078 @default.
- W2105166821 cites W1654870552 @default.
- W2105166821 cites W1799225030 @default.
- W2105166821 cites W1853074600 @default.
- W2105166821 cites W1960196749 @default.
- W2105166821 cites W1967948255 @default.
- W2105166821 cites W1972508811 @default.
- W2105166821 cites W1988855705 @default.
- W2105166821 cites W1989327131 @default.
- W2105166821 cites W1990199438 @default.
- W2105166821 cites W1996413533 @default.
- W2105166821 cites W2000229431 @default.
- W2105166821 cites W2002045993 @default.
- W2105166821 cites W2003617876 @default.
- W2105166821 cites W2007715266 @default.
- W2105166821 cites W2009629707 @default.
- W2105166821 cites W2013714561 @default.
- W2105166821 cites W2014140361 @default.
- W2105166821 cites W2014437057 @default.
- W2105166821 cites W2015066175 @default.
- W2105166821 cites W2015519364 @default.
- W2105166821 cites W2017515560 @default.
- W2105166821 cites W2020627445 @default.
- W2105166821 cites W2023030757 @default.
- W2105166821 cites W2027970664 @default.
- W2105166821 cites W2029243559 @default.
- W2105166821 cites W2031129569 @default.
- W2105166821 cites W2032052720 @default.
- W2105166821 cites W2036723378 @default.
- W2105166821 cites W2038847166 @default.
- W2105166821 cites W2040301123 @default.
- W2105166821 cites W2041683774 @default.
- W2105166821 cites W2051886380 @default.
- W2105166821 cites W2053130264 @default.
- W2105166821 cites W2054823635 @default.
- W2105166821 cites W2054875674 @default.
- W2105166821 cites W2055471936 @default.
- W2105166821 cites W2056542586 @default.
- W2105166821 cites W2058380308 @default.
- W2105166821 cites W2059972525 @default.
- W2105166821 cites W2069414088 @default.
- W2105166821 cites W2070061120 @default.
- W2105166821 cites W2070484728 @default.
- W2105166821 cites W2071445918 @default.
- W2105166821 cites W2073219326 @default.
- W2105166821 cites W2075245660 @default.
- W2105166821 cites W2079985291 @default.
- W2105166821 cites W2087779373 @default.
- W2105166821 cites W2089218510 @default.
- W2105166821 cites W2090935417 @default.
- W2105166821 cites W2092194090 @default.
- W2105166821 cites W2093820637 @default.
- W2105166821 cites W2096008106 @default.
- W2105166821 cites W2096212076 @default.
- W2105166821 cites W2097773090 @default.
- W2105166821 cites W2101883288 @default.
- W2105166821 cites W2102044807 @default.
- W2105166821 cites W2105295066 @default.
- W2105166821 cites W2110511887 @default.
- W2105166821 cites W2111107512 @default.
- W2105166821 cites W2118785184 @default.
- W2105166821 cites W2118820778 @default.
- W2105166821 cites W2124441131 @default.
- W2105166821 cites W2126848032 @default.
- W2105166821 cites W2127746314 @default.
- W2105166821 cites W2133010718 @default.
- W2105166821 cites W2137535245 @default.
- W2105166821 cites W2138629620 @default.
- W2105166821 cites W2141870702 @default.
- W2105166821 cites W2149288191 @default.
- W2105166821 cites W2156681756 @default.
- W2105166821 cites W2161704074 @default.
- W2105166821 cites W2171078009 @default.
- W2105166821 cites W2285543173 @default.
- W2105166821 cites W2401837659 @default.
- W2105166821 cites W2409552114 @default.
- W2105166821 cites W2411578773 @default.
- W2105166821 cites W2901901843 @default.